Repligen | RGEN - Trade Debtors


Repligen reported $158.59M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Agilent USD 1.52B 34M Dec/2025
Align Technology USD 1.1B 2.38M Dec/2025
Bio Techne USD 184.61M 717K Dec/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Bruker USD 544.9M 6M Dec/2025
Charles River Laboratories USD 1.43B 54.59M Dec/2025
Danaher USD 3.91B 762M Dec/2025
Dentsply International USD 654M 8M Sep/2025
Exact Sciences USD 306.05M 47.28M Sep/2025
General Electric Aerospace USD 15.28B 1.5B Dec/2025
Henry Schein USD 1.65B 92M Dec/2025
Illumina USD 854M 125M Dec/2025
IQVIA Holdings USD 3.43B 113M Dec/2025
Mettler Toledo International USD 778.24M 90.98M Dec/2025
Myriad Genetics USD 118M 19M Sep/2025
OraSure Technologies USD 38.1M 4.06M Jun/2024
Pacific Biosciences Of California USD 29.38M 3.05M Sep/2024
Pfizer USD 18.12B 2.02B Sep/2025
Repligen USD 158.59M 9.62M Dec/2025
Revvity USD 744.67M 64.41M Dec/2025
Standard Biotools USD 13.54M 1.07M Sep/2025
Thermo Fisher Scientific USD 8.9B 11M Dec/2025
Waters USD 828.84M 80.32M Dec/2025
West Pharmaceutical Services USD 574.4M 50.6M Dec/2025